Experimental multi-center validation of a radiomics-based photonic quantum precision medicine architecture for lesion-level prediction of anti-PD-1 response in non-small cell lung cancer
This multi-center study validates the external performance of a radiomics-based photonic quantum machine learning architecture, demonstrating that a model trained on a statistically reduced feature space can match or outperform classical baselines in predicting anti-PD-1 treatment response for non-small cell lung cancer lesions.